A primary CPC was defined according to the criteria of ISHAGE (International Society of Haemotherapy and Genetic Engineering) [8], and the expression of P504S defined according to the Consensus of the American Association of Pathologists [9]; as a cell expressing both PSA and P504S and detected before definitive treatment for prostate cancer. The gene discussed is KLK3; the disease is prostate cancer.